The Portico device is the only approved transcatheter valve that can ... with diseased or damaged aortic heart valves," said Frank J. Callaghan, president of the St. Jude Medical Cardiovascular ...

ST. PAUL, Minn., St. Jude Medical, Inc., a global medical device company, today announced the first human implant of its Portico(TM) transcatheter aortic heart valve. The procedure was performed by Dr ...

St. Jude said. "The promise of the Trifecta tissue valve to potentially deliver superior hemodynamic performance to currently available stented or stentless aortic valves is very exciting," said ...

DEAR DR. ROACH: I had a St. Jude's aortic valve put in in 1998. I have taken Coumadin since that time. A couple of years ago, my doctors changed the goal for my INR to 2-3. I don't know why.

“will help us provide the best care possible for our patients in need of aortic valve replacement and especially those with challenging clinical cases.” The new Trifecta GT valve builds on St. Jude ...

--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the European CE Mark approval for the 27mm and 29mm Portico™ Transcatheter Aortic Valve ...

Medical device manufacturer, St. Jude Medical, Inc.STJ recently announced the receipt of CE Mark approval for its 27mm and 29mm Portico Transcatheter Aortic Valve Replacement (TAVR) Systems.

further expanding the St. Jude Medical valve product portfolio, which includes market-leading mechanical heart valves, aortic and mitral tissue valves, valve repair annuloplasty rings and the ...